Fundraising Fox
/Companies
Sign in

10x Science

YC W26

San Francisco, US · Founded 2025 · 5 employees · Hiring · 4 known investors

Find your way into 10x Science

Each arrow is one introduction. Sign up to fill in the first one.

10,471 people can intro you to David

Ask Chandra Duggirala to introduce you to David Roberts

You →Chandra · together at FounderPool →David

10,409 people can intro you to Vishnu

Ask Jamie Chen to introduce you to Vishnu Tejus

You →Jamie · together at Nooks →Vishnu

10,406 people can intro you to Andrew

Ask Sam Okafor to introduce you to Andrew Reiter

You →Sam · together at YC W26 →Andrew

Sign up to find every way you can get introduced to 10x Science

  • Your email: who you already know at 10x Science, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the 10x Science team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

10x Science provides an AI platform that automates protein characterization for drug developers, reducing months of manual analysis to speed the evaluation of therapeutic candidates in early-stage development.

AI & Machine LearningBiotechEnterprise SoftwareSaaSB2BAIUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W26)

10x Science was founded in 2025 by David Roberts, Andrew Reiter, and Vishnu Tejus.

DRDavid Roberts
David RobertsFounderDavid Roberts holds a B.S. in chemistry and mathematics from UC San Diego and a Ph.D. in materials and analytical chemistry from the University of Wisconsin-Madison. He completed postdoctoral research in chemical biology at Stanford University as a Damon Runyon Cancer Research Fellow.
ARAndrew Reiter
Andrew ReiterFounderAndrew Reiter holds a B.S. in Biology from UNC-Chapel Hill and completed a Ph.D. in Biology at Stanford University under the co-advising of Carolyn Bertozzi and Or Gozani. He previously worked at the Broad Institute developing mass spectrometry methods in the Proteomics Platform Lab.
VTVishnu Tejus
Vishnu TejusFounder and CTOVishnu Tejus founded Nooks as a second hire and founding engineer, developing AI for go-to-market teams. He subsequently conducted research in analytical chemistry and cancer biology at the University of Washington, UCSF, and Stanford, publishing in peer-reviewed journals.

Investors · 4

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · tamradar.com · open dataset · 5k.vc investor directory · Not right? Tell us

Civilization Ventures Management, LlcreportedTiburon · $1M – $10M

How we know: tamradar.com · Not right? Tell us

Also in the syndicate · 1

Founder Factor

Funding

SEC filings, press & company announcements

$4.8M disclosed across 1 round · 2026

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 7

10X Genomics10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.
InferaInfera converts natural language descriptions of lab experiments into executable protocols for laboratory instruments, managing protocol logic, vendor-specific configurations, data, and inventory across an integrated system.
DelineateDelineate builds AI agents that help pharmaceutical companies design clinical trials more quickly by converting existing trial research into specialized datasets, reducing the time scientists spend on trial preparation.
PanoptivePanoptive provides a software platform that continuously monitors clinical trials by converting monitoring reports and electronic data capture (EDC) data into structured findings, documented decisions, and audit-ready oversight records. The platform serves sponsors and clinical operations teams conducting regulated trials and helps organizations surface quality issues early while maintaining inspection-ready documentation.
FrekilFrekil automates real-world evidence generation for pharmaceutical and healthcare research, using AI agents to build patient cohorts, design studies, and generate statistical analyses from existing clinical data. The platform enables epidemiological workflows across drug safety monitoring, comparative effectiveness, label expansion, and trial feasibility assessments.
10x Founders10x Founders is an early-stage venture investor operating an international network of entrepreneurs and investors, primarily across Europe and the US. The firm backs early-stage startups, with its six partners having been early investors in companies such as Adyen, EquipmentShare, and Luminar.
OsseusOsseus builds a permissioned research brain that connects tools and data across R&D teams to surface past experiments, expert knowledge, and next actions. The platform serves technical and research teams in biotech, manufacturing, and similar knowledge-intensive industries by maintaining continuous memory of how work evolved and preventing repeated efforts.

Companies working in the same space as 10x Science.

In the news

10x Science Raises $4.8M in Seed Fundingfinsmes.com · Apr 2026AI is spitting out more potential drugs than ever. This startup wants to figure out which ones matter. | TechCrunchtechcrunch.com · Apr 202610x Science: Unlocking the future of drug development 🔑🧬ycombinator.com · Feb 2026

Frequently asked questions

What does 10x Science do?
10x Science provides an AI platform that automates protein characterization for drug developers, reducing months of manual analysis to speed the evaluation of therapeutic candidates in early-stage development.
Who founded 10x Science?
10x Science was founded by David Roberts, Andrew Reiter, Vishnu Tejus in 2025.
Who are 10x Science's investors?
10x Science's investors include Initialized Capital, Y Combinator, Civilization Ventures Management, Llc.
How much funding has 10x Science raised?
10x Science has disclosed $4.8M raised across 1 round.
Where is 10x Science headquartered?
10x Science is headquartered in San Francisco, US.